Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats

Toxicology

Volumn 219, Issue 1-3, 2006, Pages 53-59

  Santhosh, S ^a,b   Sini, T K ^a   Anandan, R ^a   Mathew, P T ^a  

^a CENTRAL INSTITUTE OF FISHERIES TECHNOLOGY   (India)

^b Souparnika   (India)

Author keywords

Chitosan; Diagnostic marker enzymes; Hepatotoxicity; Isoniazid; Lipid peroxidation; Lipids; Rifampicin

Indexed keywords

ACID PHOSPHATASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHITOSAN; CHOLESTEROL; FATTY ACID; ISONIAZID; LACTATE DEHYDROGENASE; PHOSPHOLIPID; RIFAMPICIN; TRIACYLGLYCEROL; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; LIVER; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTITUBERCULAR AGENTS; CHITOSAN; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; HEPATITIS, TOXIC; ISONIAZID; LIPID PEROXIDATION; LIPID PEROXIDES; LIVER; LIVER FUNCTION TESTS; MALE; RATS; RATS, WISTAR; RIFAMPIN; TRIGLYCERIDES;

ANIMALIA;

EID: 31044431993     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.11.001     Document Type: Article

References (46)

1. M.R. Alexander, S.G. Louie, and B.G. Guernsey Isoniazid associated hepatitis Clin. Pharmacol. 1 1982 148 153
2. G.G. Allan, L.C. Altman, R.E. Bensinger, D.K. Ghosh, Y. Hirabayashi, A.N. Neogi, and S. Neogi Chitin, Chitosan and Related Enzymes 1984 Academic Press Inc. Orland 119 133
3. A. Amr, and A.H. Alaa Oxidative stress mediates drug-induced hepatotoxicity in rats: a possible role of DNA fragmentation Toxicology 208 2005 367 375
4. R. Anandan, Suseela Mathew, and P.G. Viswanathan Nair Antiulcerogenic effects of chitin and chitosan on mucosal antioxidant defense system in HCl-ethanol induced ulcer in rats J. Pharm. Pharmacol. 56 2004 265 269
5. M.S. Brown, and J.L. Goldstein A receptor mediated pathway for cholesterol homeostasis Science 232 1986 34 47
6. M. Burstein, and H.R. Scholnick Precipitation of chylomicron and very low density lipoprotein from human serum with sodium lauryl sulphate Life Sci. 11 1972 177 184
7. J. Doroshow, and P. Hochstein Redox cycling and the mechanism of action of antibiotics in neoplastic diseases Pathology of Oxygen 1982 Academic Press New York 245 250
8. R.A. Eidelman, G.S. Lamas, and C.H. Hennerkens The new national education program guidelines Arch. Intern. Med. 162 2002 2033 2036
9. J. Filipovic-Grcic, N. Skalko-Basnet, and I. Jalsenjak Mucoadhesive chitosan-coated liposomes: characteristics and stability J. Microencapsul. 18 2001 3 12
10. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J. Biol. Chem. 66 1925 375 400
11. J. Folch, M. Lees, and G.H.S. Stanely A simple method for isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
12. J.C. Gibson, W.H. Lee, and Z.F. Stephan The ansamycins: a novel class of hypolipidemic agents with a high affinity for lipoproteins Atherosclerosis 112 1995 47 57
13. L.K. Han, Y. Kimura, and H. Okuda Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet Int. J. Obes. Relat. Metab. Disord. 23 1999 174 179
14. W.T. Horn, and L.A. Menahan A sensitive method for determination of free fatty acids in plasma J. Lipid Res. 122 1981 377 381
15. M. Imogen, W. Julia, F. Sarah, and W. Roger Anti-tuberculous therapy and acute liver failure The Lancet 345 1995 555 556
16. S. Karthikeyan Isoniazid and rifampicin treatment on phospholipids and their subfractions in liver tissue of rabbits Drug Chem. Toxicol. 28 2005 273 280
17. J. King D. Van Lactate Dehydrogenase in Practical Clinical Enzymology 1965 Nostrand Co. London 83 93
18. J. King D. Van Lactate Dehydrogenase in Practical Clinical Enzymology 1965 Nostrand Co. London 191 208
19. H.J. Kissler, J. Hauffen, R. Hennig, H. Gepp, and P.O. Schwille Glucose and lipid metabolism after liver transplantation in inbred rats: consequences of hepatic denervation Metabolism 54 2005 881 890
20. S. Krisana, S. Khatcharin, R. Tawun, M. Nongnuj, U. Werasak, and H. Supot Solvation structure of glucosamine in aqueous solution as studied by Monte Carlo simulation using ab initio fitted potential Chem. Phys. Lett. 395 2004 233 238
21. F.A. Kruger, E.G. Leighty, and A.M. Weissler Catecholamine stimulation of myocardial lipolysis and fatty acid reesterification J. Clin. Invest. 46 1967 1080 1081
22. P. Madhavan Chitin and chitosan and their novel applications Popular Science Lecture Series - April 1992 Central Institute of Fisheries Technology Cochin, India 10 11
23. H.N. Mindie, and G. Gabriel Does isoniazid cause more serious hepatotoxicity in Hepatitis B virus carriers? Am. J. Gastroenterol. 97 2002 1092 1093
24. A. Mohur, and I.J.Y. Cook Simple methods for measuring serum levels of glutamic-oxalo acetic and glutamic-pyruvic transaminase in routine laboratories J. Clin. Pathol. 10 1957 394 399
25. T. Mori, M. Okumura, M. Matsuura, K. Ueno, S. Tokura, Y. Okamoto, S. Minami, and T. Fujinaga Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro Biomaterials 18 1997 947 951
26. S.D. Nelson, J.R. Mitchell, J.A. Timbrell, W.R. Snodgrass, and G.B. Corcoran III Isoniazid and isopronisid: activation of metabolites to toxic intermediate in man rat Science 192 1976 901 903
27. K. Nishimura, S. Nishimura, N. Nishi, I. Saiki, S. Tokura, and I. Azuma Immunological activity of chitin and its derivatives Vaccine 2 1984 93 99
28. R.J. O'Brien, M.W. Long, S.C. Floy, M.A. Lyle Jr., and D.E. Snider Hepatotoxicity from isoniazid and rifampicin among children treated for tuberculosis Pediatrics 72 1983 491 493
29. H. Ohkawa, N. Onishi, and K. Yagi Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
30. Y. Okamoto, S. Minami, A. Matsuhashi, H. Sashiwa, H. Saimoto, Y. Shigemasa, T. Tanigawa, Y. Tanaka, and S. Tokura Polymeric N-acetyl-d- glucosamine (chitin) induces histionic activation in dogs J. Vet. Med. Sci. 55 1993 739 742
31. A.C. Parekh, and D.H. Jung Cholesterol determination with ferric acetate-uranil acetate and sulphuric acid-ferrous sulphate reagents Anal. Chem. 42 1970 1423 1427
32. O. Pepicelli, E. Fedele, M. Berardi, M. Raiteri, G. Levi, A. Greco, M.A. Ajmone-Cat, and L. Minghetti Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-d-aspartate receptors in rat hippocampus J. Neurochem. 93 2005 1561 1567
33. P.C. Ramachandran Chemotherapy of tubercular meningitis with isoniazid plus rifampicin. Kinterim findings in a trial in children Ind. J. Tuberc. 27 1980 54 56
34. E.W. Rice Triglycerides in serum P. Roedrick R.P. Mc Donald Standard Methods in Clinical Chemistry 1970 Academic Press New York 215 218
35. P.L. Sapelli, V. Baldassarre, R.A.A. Muzzarelli, and M. Emanulli Chitin and Nature and Technology 1986 Plenum Press New York 507 512
36. S.D. Saraswathy, and C.S. Shyamala Devi Modulating effect of Liv.100, an ayurvedic formulation on antituberculosis drug-induced alterations in rat liver microsomes Phytother. Res. 15 2001 501 505
37. T.K. Sini, S. Santhosh, and P.T. Mathew Study of the influence of processing parameters on the production of carboxymethylchitin Polymer 46 2005 3128 3131
38. N.P. Skakun, and Y. Slivka The correction of hepatotoxicity of antitubercular preparations with tocopherol acetate and riboxin Eksp. Klin. Farmakol. 55 1992 52 54
39. D.E. Snider, M.W. Long, F.S. Cross, and L.S. Farer Six months isoniazid-rifampicin therapy for pulmonary tuberculosis. Report of a United States Health Service Cooperative trial Am. Rev. Respir. Dis. 129 1984 573 578
40. M.A. Steele, R.F. Burk, and R.M. Des Prez Toxic hepatitis with isoniazid and rifampicin - a meta analysis Chest 99 1991 465 468
41. D. Stenberg Interconvertible enzymes in adipose tissue regulated by cyclic AMP-dependent protein kinase Adv. Cyclic Nucleotide Res. 7 1976 157 198
42. S.A. Tasduq, K. Peerzada, S. Koul, R. Bhat, and R.K. Johri Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin Hepatol. Res. 31 2005 132 135
43. S. Tokura, K. Ueno, S. Miyazaki, and N. Nishi Molecular weight dependent antimicrobial activity by chitosan Macromol. Symp. 120 1997 1 9
44. J.F. Westphal, D. Vetter, and J.M. Brogard Hepatic side effects of antibiotics J. Antimicrob. Chemother. 33 1994 387 401
45. R. Xing, S. Liu, Z. Guo, H. Yu, P. Wang, C. Li, Z. Li, and P. Li Relevance of molecular weight of chitosan and its derivatives and their antioxidant activities in vitro Bioorg. Med. Chem. 13 2005 1573 1577
46. H.T. Yao, and M.T. Chiang Plasma lipoprotein cholesterol in rats fed a diet enriched in chitosan and cholesterol J. Nutr. Sci. Vitaminol. 48 2002 379 383